MarketScreener Strategies Medexus Pharmaceuticals Inc.

Equities

Market Closed - Toronto S.E. Other stock markets 15:59:30 2024-05-21 EDT			5-day change	1st Jan Change
1.62 ^CAD	+1.25%		+1.25%	-34.41%

03-26	Medexus Pharmaceuticals Announces US Food and Drug Administration Approves It's Supplemental Biologics License Application for IXINITY(R)	CI
02-09	Medexus Pharmaceuticals Maintained at Speculative Buy at Stifel GMP After Fiscal Q3 Miss; Price Target Cut to C$2.85	MT

No results for this search